CAS 1613373-33-3

Fórmula: C29H32F3N5O6S

InChI: InChI=1S/C29H32F3N5O6S/c1-17-15-20(37-26(40)34-24(38)27(37,3)4)16-18(2)22(17)9-14-44(41,42)36-12-10-28(11-13-36)25(39)33-23(35-28)19-5-7-21(8-6-19)43-29(30,31)32/h5-8,15-16H,9-14H2,1-4H3,(H,33,35,39)(H,34,38,40)

Clave InChI: LDZJFVOUPUFOHX-UHFFFAOYSA-N

SMILES: CC1=CC(=CC(=C1CCS(=O)(=O)N2CCC3(CC2)C(=O)NC(=N3)C4=CC=C(C=C4)OC(F)(F)F)C)N5C(=O)NC(=O)C5(C)C

PCO371

CAS: 1613373-33-3

PCO371 (2,4-Imidazolidinedione, 1-(3,5-dimethyl-4-(2-((4-oxo-2-(4-(trifluoromethoxy)phenyl)-1,3,8-triazaspiro(4.5)dec-1-en-8-yl)sulfonyl)ethyl)phenyl)-5,5-

Fórmula: C₂₉H₃₂F₃N₅O₆S

Pureza: 98.00% - 99.25%

Forma y color: Solid

Peso molecular: 635.654

Ref: TM-T16442

PCO371

CAS: 1613373-33-3

PCO371

Fórmula: C₂₉H₃₂F₃N₅O₆S

Pureza: ≥95%

Peso molecular: 635.65

Ref: 54-BUP12908

PCO371

CAS: 1613373-33-3

Fórmula: C₂₉H₃₂F₃N₅O₆S

Pureza: 95%

Forma y color: Solid

Peso molecular: 635.6545

Ref: IN-DA01JIYH

PCO371

CAS: 1613373-33-3

Ph. I for parathyroid hormone disorders

Fórmula: C₂₉H₃₂F₃N₅O₆S

Pureza: Min. 95%

Peso molecular: 635.7 g/mol

Ref: 3D-NPC37333